OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Similar documents
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

FREE WEBINAR July 18, :30 pm. Opioids and Older Minnesotans: What to Know and What to Do

Presbyterian Centennial Care. Substance Use Disorder Services and Supports

Patient and Family Agreement on Opioids

Psychosocial Treatments for Opioid Use Disorder Overview

Your Child s Treatment Roadmap

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Responding to the Opioid Epidemic

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

Understanding Medication in Addiction Treatment for Drug Court Participants

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

Substance Use Disorders in Primary Care

The Role of Urgent Care in responding to the opioid Crisis

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

Family Health Centers of San Diego Alcohol and Other Drug Services

Opioid Use Disorders &Medication Treatment

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

State Opioid Response (SOR) Grant

Vivitrol/Suboxone. Comparison Study Summary

The science of the mind: investigating mental health Treating addiction

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018

Opioid Use in Youth. Amy Yule M.D. March 2,

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Treatment Alternatives for Substance Use Disorders

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

Medication Assisted Treatment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

Opiate Use Disorder and Opiate Overdose

Vivitrol Vs. Suboxone

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives

Worcester EMS 55 Lake Avenue North Page _1_of _1_ Any Town, WI CITY: SHR WORC SOCIAL SECURITY NUMBER POLICY NUMBER

Substance Abuse. Heather Gotham, PhD, Licensed Clinical Psychologist September 9, TB Nurse Case Management September 7-9, 2016 San Antonio, TX

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Note: The trainings below represent a foundational list, and may be adapted based on audience and need.

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Division of Mental Health and Addiction Services

Recovery U: Medication Assisted Treatment (MAT)

MEDICATION ASSISTED TREATMENT

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

OPIOID WORKGROUP LEADERSHIP TEAM

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry

People inject, sniff, snort, or smoke heroin. Some people mix heroin with crack cocaine, a practice called speedballing.

Opioid Dependence and Buprenorphine Management

Fighting Today s Opioid Epidemic

Opioid Task Force Kick-Off Meeting. February 29, 2016

Buprenorphine as a Treatment Option for Opioid Use Disorder

Note: The trainings below represent a foundational list, and may be adapted based on audience and need.

What I Want From Treatment User Information

Aetna s Initiative on the Opioid Epidemic

NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project

It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs

Medication Supported Recovery- A Review of Evidence-Based Practice

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

SUBOXONE TREATMENT PROGRAM

The Opioid Epidemic in Philadelphia Implementation of the Mayor s Task Force Recommendations

Continuing Care Strategies for Long Term Recovery

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

The Value of Engagement in Substance Use Disorder (SUD) Treatment

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

Medication Assisted Treatment Specialist - MATS

Buprenorphine and MAT 101

Medication for Addiction Treatment (MAT)

The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School

Treatment Team Approaches in Substance Abuse Treatment

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioids Research to Practice

Medication Assisted Treatment of Substance Use Disorders

Department of Public Health Bureau of Substance Abuse Services - BSAS. Luisa Fundora, MSW Regional Manager BSAS/ MA DPH

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

Improving the Quality of Addiction Treatment

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

EI Leadership April 24, 2018

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Building Community Coalitions to Address the Opioid Crisis

DHCS Tribal MAT Project

Clackamas County Overdose Prevention and Recovery Support Projects. Apryl L. Herron, MPH Clackamas County Public Health Division

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Transcription:

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) Case 105- Prep Materials University of Massachusetts Medical School Opioid Conscious Curriculum

Learner Prep Objectives The purpose of this prep material is to prepare you for the Opioid Safe-Prescribing Training Immersion (OSTI) Curriculum The following slides provide an introduction to some of the key tools that you should be familiar with before participating in the OSTI. Note that additional information and resources are in the notes section of these slides and on the website. By the end of this prep, you should be familiar with the following tools and concepts: Referring treatment resources including early discussion of medication assisted therapy (MAT) Administering and using readiness to change/confidence in change tool Recognition and early management of a patient who has overdosed Discussing Naloxone use Using the Screening, Brief Intervention and Referral for Treatment (SBIRT) tool Reading an EMS run sheet

Case 5- Learner Tasks 1. Take a substance use history 2. Talk to the patient about her substance use treatment history, what has worked well previously, and options for future treatment 3. Utilize SBIRT to develop a plan with the patient, including assessment of readiness and confidence in change 4. Ensure that the patient and partner can identify signs of opioid overdose 5. Demonstrate use of a naloxone atomizer (intranasal naloxone) and explain when and how to use it to patient and partner 6. Counsel patient regarding the chronic nature of substance use disorder as a disease 7. Evaluate history and risk of psychiatric comorbidity and opioid misuse

Recognition of Opioid Overdose Classic triad: Coma (depressed mental status) Pinpoint pupils Respiratory depression (<12 breaths/min in adults) All three may not be present

Management of Opioid Overdose In medical setting: Restoration of oxygenation and ventilation are the first priorities Ventilation with BVM, supplemental oxygen administration Reversal using naloxone with escalating doses (dose titrated to restoration of respiration; excessive dosing may precipitate withdrawal) Naloxone dosing per table on following page

Naloxone and opiate overdose Death generally occurs within 1-3 hours of overdose (Kin, 2009) Bystander naloxone use is associated with increased odds of recovery (Giglio, 2015) Discuss Naloxone with all patients who have an opiate use disorder Explain signs and symptoms of overdose Share handouts and review naloxone use Share website with videos regarding OD recognition and naloxone use by patients and bystanders

How to administer nasal naloxone From Prescribe to Prevent Three minute high-yield video -- Watch it here

Patient Handout OD & Naloxone

Screening, Brief Intervention, Referral to Treatment (SBIRT) Consists of Screening: assess the level of use, reasons for use, and other important factors (there are many specific tools and additional SBIRT information on the SAMHSA website) Brief intervention: engage the patient in conversation, consider using ruler to assess interest/willingness to change Referral to Treatment: based on availability and the patient s specific needs, interest, insurance. Watch this 7 minute video on using SBIRT for drug use Consider using an SBIRT app

Readiness/Confidence to Change Provides a framework for allowing the patient to address the motivation to change through importance, readiness, and confidence Asks patients to use a 10-point ruler (mostly validated in tobacco and Alcohol behavioral change) Miller 1991, Rollnick 1997, Boudreaux 2012, Zimmerman 2000 The patient is asked to score each of these items for the habit being addressed (e.g., heroin use) Providers then ask questions about their scoring Why not lower? can provide insight into their motivation Why not higher? can identify perceived obstacles An example ruler follows

Readiness/Confidence to Change

Substance Use Disorder Treatment

Substance Use Disorder Treatment is a continuum A given patient may need some or all of these levels of care at some point in their addiction; however, not all do

Substance Use Disorder Treatment Spectrum There are several options for SUD treatment. Patients may be amenable or eligible for more than one. Examples: Individual and group counseling Inpatient and residential treatment Intensive outpatient treatment Partial hospital prog. Case/care mgmt. Medication Peer supports 12-Step fellowship Recovery support svcs

Vocabulary for the SUD Inpatient Treatment Inpatient Detoxification Program ( Detox ): 4-6 days of inpatient medical monitoring of withdrawal symptoms. Focus on medical management of symptoms, some counseling services included. Clinical Stabilization Services (CSS): Intensive, short-term (up to 30 days) inpatient residential program. Focus on skills for early recovery. Transitional Support Service (TSS): Inpatient treatment (counseling, skills building) stepdown in transition to next step in care (often longer-term residential). Usually < 28 days. Short-Term Residential Treatment: 24 hours a day care, generally in non-hospital settings, often in therapeutic community model with varied lengths of stay of between 30 days-6months Long Term Residential Treatment: Residential treatment between 6 and 12 months Alcohol and Drug-Free Housing AKA Sober Home : Typically unstructured community of individuals in recovery from addiction, often requires drug monitoring is not state-regulated or licensed; Quality and intensity of housing varies; Many private companies, Half-way House: May refer to a Sober Home with more intensive treatment engagement requirements for individuals between residential treatment and independent sober living. Three-quarter House: May refer to Sober Home with fewer requirements than a half-way house, but more than minimum sober home requirements

Vocabulary for SUD Outpatient Treatment Partial Hospitalization Program: Intensive outpatient treatment usually 5 days/week all day group counseling and skills workshops Intensive Outpatient Program (IOP): Usually half-day 3-4 days/week group counseling and skills workshops Group counseling: Often once or twice weekly for 1-2 hours. Type of group is determined by the therapist and can include support groups, skills development and psychoeducational Individual counseling: One-on-one counseling sessions with behavioral health specialist Alcoholics Anonymous/Narcotic Anonymous: 12-step model (See below) Sponsor: An individual in recovery addict who is willing to share their knowledge with those who are less experienced in the program Resource for information about recovery Someone who is available to listen, guide Role model

Medication Assisted Treatment (MAT) To date, there is strong evidence to support the use of MAT (usually methadone, buprenorphine or naltrexone) in opioid addiction. Decreases withdrawal in the early phases of recovery Decreases cravings Decreases risky activities associated with obtaining medications or drugs Increases patient retention https://www.samhsa.gov/medication-assistedtreatment/treatment#medications-used-in-mat

Narcotics Anonymous Mutual aid groups like AA and NA have frequent meetings, and require no financial resources or insurance to participate 12-step programs Focus tends to be on drug-free living, sometimes to the exclusion of MAT Your patient may have a sponsor through AA or NA, that serves as additional support http://www.na.org/admin/include/spaw2/uploads/pdf/pr/information_about_na.p

Key Concepts Opioid use disorder (OUD) is a chronic illness and should be treated as such. The opiate epidemic has impacted communities of color for years. The current national focus suggests bias not only in prescribing, but in the response of the healthcare system, policy-makers and media. Safe prescribing does NOT mean NO prescribing -- even for patients in recovery. The prescription monitoring program (PMP or MassPAT) provides accurate, up to date prescribing information Co-prescribing naloxone should be considered for any patients on chronic opiates. Best practices include risk assessment (including diversion), informed consent, monitoring, safe storage and disposal counseling.